These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 14666519

  • 1. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion.
    Srinivasan J, Schmidt WJ.
    Synapse; 2004 Mar 01; 51(3):213-8. PubMed ID: 14666519
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J, Schmidt WJ.
    Eur J Neurosci; 2003 Jun 01; 17(12):2586-92. PubMed ID: 12823465
    [Abstract] [Full Text] [Related]

  • 3. Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
    Srinivasan J, Schmidt WJ.
    Behav Brain Res; 2004 Oct 05; 154(2):353-63. PubMed ID: 15313023
    [Abstract] [Full Text] [Related]

  • 4. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J, Schmidt WJ.
    Behav Brain Res; 2004 May 05; 151(1-2):191-9. PubMed ID: 15084435
    [Abstract] [Full Text] [Related]

  • 5. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep 05; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

  • 6. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
    Dekundy A, Pietraszek M, Schaefer D, Cenci MA, Danysz W.
    Brain Res Bull; 2006 Apr 14; 69(3):318-26. PubMed ID: 16564428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    J Neurosci Methods; 2005 May 15; 144(1):35-45. PubMed ID: 15848237
    [Abstract] [Full Text] [Related]

  • 9. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ, Chen Z, Liu FX, Hu DN, Luo JH.
    Neuropharmacology; 2007 Dec 15; 53(7):832-41. PubMed ID: 17919665
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations.
    Ferro MM, Bellissimo MI, Anselmo-Franci JA, Angellucci ME, Canteras NS, Da Cunha C.
    J Neurosci Methods; 2005 Oct 15; 148(1):78-87. PubMed ID: 15939479
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
    Bilbao G, Ruiz-Ortega JA, Miguens N, Ulibarri I, Linazasoro G, Gómez-Urquijo S, Garibi J, Ugedo L.
    Brain Res; 2006 Apr 21; 1084(1):175-84. PubMed ID: 16574080
    [Abstract] [Full Text] [Related]

  • 15. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J, Hu LF, Liu X, Zhou F, Ding JH, Hu G.
    Life Sci; 2006 Mar 20; 78(17):1940-4. PubMed ID: 16216278
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
    Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I.
    Behav Brain Res; 2004 May 05; 151(1-2):303-12. PubMed ID: 15084446
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ, Bian GL, Bai Y, Cao R, Chen LW.
    Neurochem Int; 2008 Sep 05; 53(3-4):56-62. PubMed ID: 18639597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.